DFB Healthcare Acquisitions Corp.

Equities

AHCO

US23291E1091

Delayed Nasdaq Other stock markets 11:18:46 2021-10-05 am EDT			5-day change	1st Jan Change
23.49 ^USD	-0.29%		-0.88%	-37.27%

Apr. 17	AdaptHealth Names Suzanne Foster as CEO	MT
Feb. 28	UBS Adjusts AdaptHealth Price Target to $13 From $9, Maintains Buy Rating	MT

ADAPTHEALTH CORP. : Change in Directors or Principal Officers (form 8-K)

August 30, 2021 at 04:13 pm EDT

Item 5.02. Departure of Directors or Certain Officers? Election of Directors? Appointment of Certain Officers? Compensatory Arrangements of Certain Officers.





Director Resignation

On August 24, 2021, Alan Quasha submitted a notice of resignation, effective as of September 1, 2021, as a member of the Board of Directors of AdaptHealth Corp. (the "Company"). Mr. Quasha had no disagreement with the Company in connection with his resignation.





                                     - 2 -

Latest news about DFB Healthcare Acquisitions Corp.

AdaptHealth Names Suzanne Foster as CEO	Apr. 17	MT
UBS Adjusts AdaptHealth Price Target to $13 From $9, Maintains Buy Rating	Feb. 28	MT
Deutsche Bank Adjusts AdaptHealth Price Target to $10 From $8, Maintains Hold Rating	Feb. 28	MT
AdaptHealth's Q4 Loss Widens, Revenue Rises; Provides 2024 Revenue Guidance; Shares Climb	Feb. 27	MT
Earnings Flash (AHCO) ADAPTHEALTH Posts Q4 Revenue $858.2M, vs. Street Est of $825.5M	Feb. 27	MT
UBS Trims AdaptHealth Price Target to $9 From $10, Maintains Buy Rating	Jan. 29	MT
UBS Adjusts AdaptHealth Price Target to $10 From $18, Maintains Buy Rating	Nov. 08	MT
BofA Securities Downgrades AdaptHealth to Underperform From Neutral, Adjusts Price Target to $6.50 From $9.50	Nov. 08	MT
AdaptHealth Facing Headwinds Due to Slower-Than-Expected Patient Transitions, BofA Says	Nov. 08	MT
Deutsche Bank Adjusts AdaptHealth Price Target to $8 From $14, Maintains Hold Rating	Nov. 08	MT
RBC Cuts Price Target on AdaptHealth to $13 From $18, Keeps Outperform Rating	Nov. 08	MT
Earnings Flash (AHCO) ADAPTHEALTH Reports Q3 Revenue $804M, vs. Street Est of $796.6M	Nov. 07	MT
BofA Securities Adjusts AdaptHealth's Price Target to $11 From $13, Keeps Neutral Rating	23-09-22	MT
AdaptHealth Chief Executive Officer Steps Down	23-09-20	MT
AdaptHealth's New CEO Gets Court Order Preventing Him From Assuming Role Until Oct. 15	23-08-29	MT
Sector Update: Health Care Stocks Slipping Late Afternoon	23-08-17	MT
Sector Update: Health Care	23-08-17	MT
AdaptHealth Shares Decline as Newly Appointed CEO Faces Lawsuit Over Alleged Trade-Secrets Concerns	23-08-17	MT
Deutsche Bank Raises AdaptHealth Price Target to $14 From $11.30, Maintains Hold Rating	23-08-14	MT
UBS Adjusts AdaptHealth Price Target to $18 From $15, Maintains Buy Rating	23-08-09	MT
AdaptHealth's Q2 Earnings Flat, Revenue Rises; 2023 Revenue Guidance Tops Street View; Shares Rise	23-08-08	MT
Earnings Flash (AHCO) ADAPTHEALTH Reports Q2 Revenue $793.3M, vs. Street Est of $765.2M	23-08-08	MT
Alignment Healthcare Names Christopher Joyce Chief Legal and Administrative Officer	23-07-17	MT
Baird Adjusts Price Target on AdaptHealth to $21 From $20, Maintains Outperform Rating	23-07-13	MT
AdaptHealth Names Crispin Teufel Chief Executive	23-06-27	MT

Chart DFB Healthcare Acquisitions Corp.

Duration

Period

More charts

Company Profile

Sector

More about the company